Arcellx Inc (ACLX)
48.96
-0.78
(-1.57%)
USD |
NASDAQ |
May 13, 14:13
Arcellx Price: 48.96 for May 13, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 10, 2024 | 51.81 | 52.73 | 47.88 | 49.74 | 895813.0 |
May 09, 2024 | 52.12 | 53.48 | 51.59 | 52.73 | 377239.0 |
May 08, 2024 | 52.08 | 52.64 | 50.74 | 52.25 | 545473.0 |
May 07, 2024 | 52.78 | 52.97 | 51.30 | 52.42 | 311293.0 |
May 06, 2024 | 52.54 | 53.68 | 51.02 | 52.67 | 261552.0 |
May 03, 2024 | 54.69 | 55.85 | 52.37 | 52.69 | 402998.0 |
May 02, 2024 | 52.46 | 54.05 | 51.32 | 53.29 | 295379.0 |
May 01, 2024 | 50.27 | 53.97 | 50.19 | 52.18 | 542055.0 |
Apr 30, 2024 | 50.62 | 51.60 | 49.81 | 50.02 | 500347.0 |
Apr 29, 2024 | 52.08 | 52.45 | 50.59 | 51.11 | 388007.0 |
Apr 26, 2024 | 51.35 | 52.68 | 50.87 | 51.92 | 339688.0 |
Apr 25, 2024 | 51.52 | 51.96 | 49.66 | 51.38 | 631751.0 |
Apr 24, 2024 | 54.54 | 54.94 | 52.54 | 52.82 | 312852.0 |
Apr 23, 2024 | 52.25 | 55.94 | 52.25 | 54.44 | 408988.0 |
Apr 22, 2024 | 52.28 | 53.35 | 50.54 | 52.00 | 438388.0 |
Apr 19, 2024 | 54.23 | 55.12 | 51.03 | 51.65 | 742730.0 |
Apr 18, 2024 | 53.24 | 54.89 | 52.59 | 54.50 | 692182.0 |
Apr 17, 2024 | 55.87 | 55.87 | 53.25 | 53.55 | 472430.0 |
Apr 16, 2024 | 56.34 | 56.75 | 54.80 | 55.22 | 747629.0 |
Apr 15, 2024 | 58.08 | 59.14 | 56.87 | 56.96 | 381994.0 |
Apr 12, 2024 | 59.73 | 59.80 | 57.55 | 58.07 | 496250.0 |
Apr 11, 2024 | 59.54 | 60.51 | 59.22 | 60.17 | 326594.0 |
Apr 10, 2024 | 58.90 | 60.29 | 58.51 | 59.08 | 521314.0 |
Apr 09, 2024 | 60.60 | 61.32 | 59.42 | 60.56 | 489982.0 |
Apr 08, 2024 | 62.80 | 62.80 | 60.24 | 60.70 | 407301.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
7.21
Minimum
May 18 2022
73.49
Maximum
Mar 20 2024
33.29
Average
31.95
Median
Price Benchmarks
Gilead Sciences Inc | 67.14 |
Eli Lilly and Co | 757.34 |
Viking Therapeutics Inc | 71.62 |
Blueprint Medicines Corp | 106.40 |
NovaBay Pharmaceuticals Inc | 0.0813 |
Price Related Metrics
PS Ratio | 21.33 |
Price to Book Value | 5.326 |
Price to Free Cash Flow | 12.64 |
Earnings Yield | -3.00% |
Market Cap | 2.585B |